CPT code 0267U: Genome test, mapping plus sequencing2026 Medicare lab fee · Clinical Laboratory Fee Schedule
Optical genome mapping combined with whole-genome sequencing detects structural genomic variants associated with rare constitutional and other heritable disorders.
Medicare pays $6,739.33 for 0267U under the 2026 Clinical Laboratory Fee Schedule: one national amount, the same in every state and setting.
Medicare lab fee · CLFS 2026 Q4
National CLFS amount
$6,739.33
In effect since Jan 1, 2026. The same amount in every state, payment locality and setting.
- Geographic adjustment
- None
- Office vs facility
- Same
- Since 2023
- Unchanged
- CMS updates
- Quarterly
Medicare pays the lesser of the lab’s charge and this amount. Patients usually owe no Part B deductible or coinsurance for covered clinical lab tests.
On this page 7 sections
What 0267U covers
0267U identifies a proprietary laboratory assay that combines optical genome mapping with whole-genome sequencing to evaluate rare constitutional and other heritable disorders. The methods detect structural genomic variants, including copy-number variations, inversions, insertions, translocations, and other structural changes. The code identifies this combined approach to rare-disease testing.
Report 0267U for this combined laboratory service. Medicare pays the code under the CLFS using one national amount that applies across states and localities, without geographic or office-versus-facility adjustment. The 2026 national CLFS amount is $6,739.33, unchanged from 2023 through 2026. Payment is through the CLFS only.
This summary was written with AI assistance from CMS Clinical Laboratory Fee Schedule data. Amounts on this page come directly from CMS files.
How Medicare pays 0267U
Clinical lab tests aren’t priced like physician services. They’re paid from their own fee schedule, with its own rules. See the whole lab fee schedule.
One national amount
CMS sets a single Clinical Laboratory Fee Schedule amount for 0267U. There’s no geographic (GPCI) adjustment, so it pays the same in every state and payment locality.
No office or facility rate
Lab tests aren’t built from relative value units, so there’s no office and facility split: the place of service doesn’t change the CLFS amount.
Updated every quarter
CMS republishes the CLFS each quarter. New tests, often proprietary laboratory analyses (PLA codes), join during the year; existing amounts are updated each January.
Not on the physician fee schedule
The physician fee schedule doesn’t list 0267U: Medicare pays the test only from the CLFS.
0267U on the lab fee schedule since 2021
0267U · CLFS 2026 Q4 (current)
$6,739.33
Unchanged since Jan 1, 2023
Every change on file
- Jan 1, 2023 · CLFS 2023 Q1MAC-priced → $6,739.33
21 quarterly CLFS releases on file, first CLFS 2021 Q4. A code missing from a quarter wasn’t on that release.
0267U compared with similar tests
- 0260UGenome mappingStructural variant detection$1,263.53
- 0260U is identified as a rare-disease optical genome-mapping test. 0267U identifies a test combining optical genome mapping with whole-genome sequencing.
- 0264UGenome mappingStructural variant detection$1,263.53
- 0264U is identified as a rare-disease optical genome-mapping test. 0267U identifies a test combining optical genome mapping with whole-genome sequencing.
- 0265UGenome sequencingRare heritable disorders$5,475.80
- 0265U is identified as rare-disease whole-genome and mitochondrial DNA analysis; 0267U combines optical genome mapping with whole-genome sequencing.
0267U billing questions
What does 0267U evaluate?
It combines optical genome mapping and whole-genome sequencing to detect structural genomic variants associated with rare constitutional and other heritable disorders.
Which structural variants are included?
The assay detects copy-number variations, inversions, insertions, translocations, and other structural variants.
How does 0267U differ from 0260U or 0264U?
Those codes are identified as rare-disease optical genome-mapping tests. 0267U identifies a test combining optical genome mapping with whole-genome sequencing; select the code that matches the assay performed.
How does Medicare pay for 0267U?
Medicare pays 0267U under the CLFS at one national amount across localities and practice settings.
Is there a separate physician fee schedule payment?
Medicare pays 0267U through the CLFS only.
Where this amount comes from
FeeBase reads lab amounts directly from the CMS Clinical Laboratory Fee Schedule file for the quarter: one row per code, with its payment indicator and national amount. Contractor-priced tests are labeled, never given a made-up amount. Amounts are Medicare payment limits, not a patient’s bill or a commercial rate.
CMS CLFS 2026 Q4 · effective Oct 1, 2026 through the day before Jan 1, 2027
Show the CMS file line behind this amount
Fee sheets · Coming soon
Put 0267U and the rest of your codes on one sheet
Your codes at your locality, with payer contracts beside Medicare.
Join the waitlist